0001821223-20-000002.txt : 20200817 0001821223-20-000002.hdr.sgml : 20200817 20200817144828 ACCESSION NUMBER: 0001821223-20-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20200817 DATE AS OF CHANGE: 20200817 EFFECTIVENESS DATE: 20200817 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Kinaset Therapeutics, Inc. CENTRAL INDEX KEY: 0001821223 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-373382 FILM NUMBER: 201109465 BUSINESS ADDRESS: STREET 1: 10 KNOLLWOOD ROAD CITY: MEDFIELD STATE: MA ZIP: 02052 BUSINESS PHONE: (508) 858-5810 MAIL ADDRESS: STREET 1: 10 KNOLLWOOD ROAD CITY: MEDFIELD STATE: MA ZIP: 02052 D 1 primary_doc.xml X0708 D LIVE 0001821223 Kinaset Therapeutics, Inc. 10 KNOLLWOOD ROAD MEDFIELD MA MASSACHUSETTS 02052 (508) 858-5810 DELAWARE None None Corporation true 2020 Robert Clarke 10 Knollwood Medfield MA MASSACHUSETTS 02052 Executive Officer Director Promoter Chief Executive Officer and Director Jamil Beg 10 Knollwood Medfield MA MASSACHUSETTS 02052 Director Director of the Issuer Kevin Bitterman 10 Knollwood Medfield MA MASSACHUSETTS 02052 Director Director of the Issuer Bram Vanparys 10 Knollwood Medfield MA MASSACHUSETTS 02052 Director Director of the Issuer Tom King 10 Knollwood Medfield MA MASSACHUSETTS 02052 Director Director of the Issuer Roger Heerman 10 Knollwood Medfield MA MASSACHUSETTS 02052 Executive Officer Promoter Chief Business Officer, Chief Operating Officer of the Issuer Frazer Morgan 10 Knollwood Medfield MA MASSACHUSETTS 02052 Executive Officer Promoter Chief Development Officer of the Issuer Pharmaceuticals Decline to Disclose 06b false 2020-07-31 true true false 375000 40000000 1500000 38500000 Upon the completion of certain milestones, the investors will be required to purchase up to an additional $38.5 million. false 3 0 0 0 false Kinaset Therapeutics, Inc. Robert Clarke Robert Clarke Chief Executive Officer and Director 2020-08-17